Krsnaa Diagnostics

Krsnaa Diagnostics Net Margin

The Net Profit Margin of Krsnaa Diagnostics (KRSNAA.NS) as of Oct 31, 2026 is 13.13 %. In the previous year, Net Profit Margin was 10.82 % — a change of 21.29% (higher).

Net Margin

13.13 %

YoY

21.29%

Last updated:

Net Profit Margin of Krsnaa Diagnostics is 2026 13.13 % . Net Profit Margin of Krsnaa Diagnostics was 2025 10.82 % . It decreases by 21.29% higher compared to the previous year.

Krsnaa Diagnostics's net margin stands at 13.1%, down from 15.0% several years earlier.

The Krsnaa Diagnostics Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
-27.75 INR
Jan 1, 2020
-43.32 INR
Jan 1, 2021
46.65 INR
Jan 1, 2022
15.02 INR
Jan 1, 2023
12.75 INR
Jan 1, 2024
9.17 INR
Jan 1, 2025
10.82 INR
Jan 1, 2026
13.13 INR
The Krsnaa Diagnostics Net Margin history
YEARNet MarginYoY
13.13 %+21.29%
10.82 %+17.98%
9.17 %-28.06%
12.75 %-15.08%
15.02 %-67.81%
46.65 %-207.68%
-43.32 %+56.12%
-27.75 %-50.38%
-55.92 %+710.63%
-6.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Krsnaa Diagnostics Stock analysis

What does Krsnaa Diagnostics do? Krsnaa Diagnostics Ltd provides diagnostic services across India, including radiology and pathology through X-Ray, CT scan, MRI, mammography, and tele-reporting. The company offers lab services for blood and urine investigations, supported by technology that aids healthcare professionals in diagnosing medical conditions. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS). The firm serves public and private hospitals, medical colleges, and community health centers as its primary customers. The company generates revenue through diagnostic service fees charged to hospitals, medical colleges, and community health centers. These institutions purchase the diagnostic services for their patients, utilizing Krsnaa's imaging and lab capabilities. The health packages are also sold to these institutions for patient care programs, contributing to the company's revenue streams. Krsnaa Diagnostics Ltd's product portfolio focuses on medical imaging and laboratory testing, targeting healthcare providers and institutions. The primary segments served are public and private hospitals, medical colleges, and community health centers, which rely on the company's diagnostic solutions for patient diagnostics and treatment planning. Krsnaa Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Krsnaa Diagnostics stock

Net Profit Margin of Krsnaa Diagnostics is 13.13 % in 2026.

Net Profit Margin of Krsnaa Diagnostics changed from 10.82 % to 13.13 %, representing a 21.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Krsnaa Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Krsnaa Diagnostics with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Krsnaa Diagnostics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Krsnaa Diagnostics